Secondary Stock OfferingsBy The Online Investor Staff, updated Sat., Sep. 19, 8:26 AM
|This Slide: #15 of 25|
Slide #15. Natera, Inc. — Secondary Offering
Natera, Inc. (NASDAQ:NTRA)
Date of Pricing:
Price Per Share:
Secondary Offering Details:
Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the pricing of its underwritten public offering of 4,166,666 shares of its common stock at a price to the public of $60.00 per share. Closing of the offering is expected to occur on September 15, 2020, subject to customary closing conditions. In addition, Natera has granted the underwriters a 30-day option to purchase up to an additional 624,999 shares of its common stock from Natera at the public offering price less the underwriting discounts and commissions.
Natera is a diagnostics company. Co. engages in the discovery, development and commercialization of genetic testing services. Co.'s product offerings include: Panorama Non-Invasive Prenatal Test, which screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Vistara, a single-gene mutations screening test performed to identify single-gene disorders; Horizon Carrier Screening, which determines carrier status for a number of severe genetic diseases that could be passed on to the carrier's children; and Spectrum, which analyzes chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos for a pregnancy.
NTRA SEC Filing Email Alerts Service
Open the NTRA Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 86% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite